Each year cancer (overall) kills 14 million people worldwide
Men are more likely than women to be diagnosed with some type of cancer during their lifetime (50 percent of men compared to 33 percent of women)
Prostate cancer is the most common non-skin cancer in the U.S., affecting one in six men
African American men have the highest incidence of prostate cancer and are 60 percent more likely to develop the disease compared to Caucasian men
Men with a family history of prostate cancer are at higher risk for developing prostate cancer
Every year more than 230,000 men are diagnosed with prostate cancer; this number increases annually as the general population of aging men increases
Prostate cancer is the second largest cancer killer of men following lung cancer; approximately 30,000 men will die this year from prostate cancer (82 men every day)
Screening for prostate cancer includes a PSA (prostate specific antigen) blood test and a DRE (digital rectal exam); a biopsy is required to diagnose prostate cancer
There is confusion over inconsistent messages about the value of PSA testing for prostate cancer; we fear that this is causing some men to forego testing for early detection resulting in physicians seeing an increase in prostate cancer initially diagnosed at an advanced stage
Rather than any “quick fix” for prostate cancer, there are many treatment options and related side effects that each patient needs to evaluate
